ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Mitigating The Risks Of Long-Term Oncology eCOA Clinical Trials

  This article digs into the specific complexities of long oncology clinical trials and describes relevant solutions to manage the risks regarding patient compliance, clinical project teams, and clinical sites.

• Real-World Data Capture With EDC

  This case study explores how a Ph.D. candidate partnered with Castor to develop software that seamlessly moves RWD between hospital systems and Castor’s EDC.

• Implementing eSource: A Guide For Operations And Technology Roles

  By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.

• Modern Decentralized Trials Demand Advanced eClinical Support

  First-generation eClinical systems can create as many challenges as they resolve. A more coherent solution is necessary to ensure data integrity, ease site burdens, and promote greater patient-centricity.

• 4 Ways Home Visits Support Successful Rare Disease Clinical Trials

  Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.

• How FAIR Data Principles Deliver Clinical Success

  Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being.

• Why Legacy RTSM Systems Create Risk in Biosimilar Trials

  Learn how real-time visibility, adaptive supply planning, and proactive risk management can reduce waste and improve study execution.

• Inova Health System Uses Advarra eReg Workflows And Integrations To Improve Regulatory Efficiency

  Maintaining efficient, effective regulatory management processes can be a significant challenge. At Inova Health System, the research team improved regulatory efficiency by 20% without the need for extra regulatory staff by adopting Advarra’s eRegulatory Management System.

• Real-World Data Vs. Real-World Evidence

  Unearth the ways real-world data (RWD) and real-world evidence (RWE) in clinical R&D can be used to provide additional validation for new therapies and drugs regarding their efficacy, safety, and value.

• Parkinson's Disease: Leveraging Wearable DHTs

  Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.